In gastric cancer, elevated expression of Gal-4 has been identified as an independent predictor of metastasis and poor clinical outcomes, functioning as a tumor promoter particularly in aggressive and poorly differentiated tumors [167]. Here, LGALS4 is linked to neoplasm.